Acorah Software Products - Accounts Production 16.1.300 false true false true No description of principal activity 8 January 2024 31 January 2025 31 January 2025 15397267 Miss Anya Rawling iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15397267 2024-01-07 15397267 2025-01-31 15397267 2024-01-08 2025-01-31 15397267 frs-core:CurrentFinancialInstruments 2025-01-31 15397267 frs-bus:PrivateLimitedCompanyLtd 2024-01-08 2025-01-31 15397267 frs-bus:FilletedAccounts 2024-01-08 2025-01-31 15397267 frs-bus:Micro-entities 2024-01-08 2025-01-31 15397267 frs-bus:AuditExempt-NoAccountantsReport 2024-01-08 2025-01-31 15397267 frs-bus:Director1 2024-01-08 2025-01-31
Registered number: 15397267
AJR Patient Experience Limited
Unaudited Financial Statements
For the Period 8 January 2024 to 31 January 2025
Townend English
Chartered Accountants
81-83 Market Street
Pocklington
YO42 2AE
Balance Sheet
Registered number: 15397267
31 January 2025
£
Fixed assets 1,085
Current assets 522
Creditors: Amounts Falling Due Within One Year (1,139 )
NET CURRENT LIABILITIES (617 )
TOTAL ASSETS LESS CURRENT LIABILITIES 468
Accruals and deferred income (720 )
NET LIABILITIES (252 )
CAPITAL AND RESERVES (252 )

Notes

1. General Information
AJR Patient Experience Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15397267 . The registered office is 53 Inglemire Avenue, Hull, HU6 7TG.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
Page 0
Page 1
For the period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Miss Anya Rawling
Director
12 March 2025